ERUPTION-2: Study of Thermoregulatory Processes in Ultra-endurance Runners in a Hot and Humid Environment

Sponsor
Centre Hospitalier Universitaire de la Réunion (Other)
Overall Status
Completed
CT.gov ID
NCT05098925
Collaborator
(none)
80
1
1
2.4
33.4

Study Details

Study Description

Brief Summary

Human beings are characterized by their extraordinary ability to thermoregulate.

During a physical exercise, only 20% of the energy provided by the substrates is converted into muscular mechanical work. The remaining 80% is released as heat. In temperate environments, so-called metabolic heat is dissipated by several physical phenomena (radiation, conduction, convection and evaporation). However, if the dissipation capacity (in a hot and humid environment for example) is lower than the production of metabolic heat, the body temperature increases progressively until exercise stops or heat-related pathologies develop. This pathological entity defined by the acronym EHI for Exertional Heat Illness gather a wide spectrum of clinical forms ranging from oedema or heat rash, to muscle cramps, to syncope; up to more serious forms such as heat exhaustion or heat stroke during exercise.

Heatstroke during exercise is the second most common cause of death in athletes after heart disease.

However, the results of the epidemiological studies and the recommendations are limited to events with effort durations or distances not exceeding those of the marathon. They therefore do not consider ultra-endurance disciplines.

These disciplines, defined by durations of effort of at least 6 hours, have specific characteristics (duration of effort, intensity, steep gradients, exotic destinations, extreme environments) which means that extrapolation of the results and knowledge of the physiology of thermoregulation from "classic" endurance events, such as marathons, to ultra-endurance events is hazardous. There are therefore significant areas of uncertainty in understanding the thermoregulatory function, prevalence of EHI (Exertional Heat Illness) and health implications of ultra-endurance running in a hot environment. This is the context of ERUPTION-2.

Condition or Disease Intervention/Treatment Phase
  • Other: Biological testing
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Study of Thermoregulatory Processes in Ultra-endurance Runners in a Hot and Humid Environment
Actual Study Start Date :
Oct 19, 2021
Actual Primary Completion Date :
Oct 24, 2021
Actual Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Study of Thermoregulatory Processes in Ultra-endurance Runners in a Hot and Humid Environment

Other: Biological testing
Blood sampling, microcapillary sampling, temperature monitoring, saliva testing, EHI questionnaire

Outcome Measures

Primary Outcome Measures

  1. Core temperature measurement [during 3 days of the race]

    Measure of core temperature (°C) will be carried out by continuous monitoring using e-Celsius performance Bodycap technology sensors carried by the athletes through the race

  2. Natremia measurement [during 3 days of the race]

    Measure of natremia (blood sodium concentration) will be made by 5 measurements carried out on the eve of the start and during the race, by microcapillary blood sample using the i-STAT technology and CHEM8+ cartridges.

  3. Hydration saliva measurement [during 3 days of the race]

    Hydration will be measured 5 times carried out on the eve of the start and during the race using saliva sample to measure the salivary osmolarity with the MX3 testing device.

  4. Hydration by weight measurement [during 3 days of the race]

    Weight in kg will be measured 5 times carried out on the eve of the start and during the race

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Runners participating in " La diagonale des fous " race of the "Grand Raid" 2021 on Reunion Island
Exclusion Criteria:
  • Runners who do not understand French

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Réunion Saint-Denis Réunion 97400

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de la Réunion

Investigators

  • Principal Investigator: Nicolas Bouscaren, MD, Centre Hospitalier Universitaire de La REUNION

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de la Réunion
ClinicalTrials.gov Identifier:
NCT05098925
Other Study ID Numbers:
  • 2021/CHU/25
First Posted:
Oct 28, 2021
Last Update Posted:
Apr 1, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 1, 2022